Astrazeneca Pharma India informs about compliances-certificate

09 Sep 2024 Evaluate
Astrazeneca Pharma India has enclosed the certificate dated September 4, 2024 issued by Integrated Registry Management Services, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

7086.75 56.40 (0.80%)
15-Jan-2025 12:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1753.00
Dr. Reddys Lab 1326.80
Cipla 1446.50
Lupin 2125.50
Zydus Lifesciences 990.95
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.